The ATP5F1A gene helps mitochondria, the cell’s energy centers, make ATP, the main fuel your cells use every day. If this gene does not work well, cells may struggle to produce enough energy, especially in the brain, muscles, and heart. People with harmful variants in the ATP5F1A gene can develop a mitochondrial condition with features such as low muscle tone, developmental delay, movement problems, seizures, or heart involvement.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or direct activities in the body. Some genes provide the code for proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes take place, where they occur, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. You can find more detailed information on this topic in the LearnHub.
Overview
ATP5F1AGene function
What if the gene works
The ATP5F1A gene helps mitochondria, your cells’ energy centers, make ATP, the main fuel cells use. This supports energy-demanding organs such as the brain, muscles, and heart.
Risk
What if the gene does not work
More disruptive variants in the ATP5F1A gene can reduce the cell’s ability to make energy, leading to a mitochondrial condition with developmental delay, low muscle tone, seizures, or heart involvement. Milder variants may cause later onset and less severe features.
Treatment
What does that mean for your treatment
No ATP5F1A-specific treatment or drug selection strategy is currently established for people with a pathogenic variant in the ATP5F1A gene. ATP5F1A is being studied within broader mitochondrial disease research, but this has not yet led to a guideline-based therapy.
Conditions associated with ATP5F1A
Gene function
What if the gene works
Every second, your cells need ATP, the small molecule that powers most body functions. The ATP5F1A gene helps make that possible inside mitochondria, the parts of cells that produce most of your cell energy. It supplies a key piece of ATP synthase, the enzyme that converts stored energy into ATP.
Protein from the ATP5F1A gene helps form the head of ATP synthase, the enzyme that makes ATP, your cells’ main energy molecule. In mitochondria, it supports the step where ADP and phosphate are joined to make usable energy.
This protein works with other ATP synthase parts to turn a flow of tiny charged particles into ATP production. That is a central step in how the ATP5F1A gene helps make ATP in mitochondria.
The ATP5F1A gene provides one of the main support pieces that help ATP synthase keep its working shape. This steady structure lets the enzyme run smoothly as cells make energy from food and oxygen.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ATP5F1A gene can alter the protein’s shape, stability, or amount, making it harder for the protein to join the cell’s main system for making energy in mitochondria and lowering ATP, the molecule cells use for energy. This is how ATP5F1A gene variants affect the protein in cells. Milder variants may leave some activity intact, while more severe variants can sharply disrupt protein folding or complex function and are often linked to earlier, more pronounced mitochondrial disease.
How variants are linked to conditions
Pathogenic variants in the ATP5F1A gene cause a rare mitochondrial disease. In disease related to the ATP5F1A gene, symptoms can include developmental delay, low muscle tone, movement problems, feeding difficulties, seizures, and sometimes heart involvement. Symptoms often begin in infancy or childhood, but severity varies from one person to another. Finding a disease-causing ATP5F1A variant can confirm the genetic diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, particularly when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ATP5F1A gene. For people with an ATP5F1A change, the main issue is the genetic change itself, and a doctor or genetic counselor can help explain what it may mean for you or your family.
Inheritance of ATP5F1A variants
Current evidence does not point to one broadly confirmed inheritance pattern for ATP5F1A-related disease, so the inheritance of ATP5F1A gene variants is still being clarified as research develops. ATP5F1A is located on chromosome 18, which is an autosome, so each person inherits one copy of the ATP5F1A gene from each parent.
What does my ATP5F1A result mean for my family?
For families with a disease-causing ATP5F1A result linked to a known condition, the pattern is usually recessive, which means close relatives may also be carriers even if they feel completely well. Brothers and sisters could sometimes have the same condition or be carriers, and adult relatives may want to learn whether they carry the same gene change before having children. Family impact depends on the exact result found in your family.
Genetic information
Genetic testing
How you find out about variants
ATP5F1A genetic testing looks for variants in the ATP5F1A gene using a blood or saliva sample. A lab reads the gene’s DNA code, often as part of a multigene panel or exome test, to see whether a variant is present and whether it helps explain a person’s symptoms or family history.
When should I consider getting a genetic test?
Genetic testing for the ATP5F1A gene may be considered when someone has signs of an inherited energy-production condition, especially early in life, such as developmental delay, seizures, low muscle tone, or heart problems. It can also help if a close relative has a confirmed ATP5F1A variant.
A genetic result is only one part of your health story
Genetic test findings can be informative, although what they reveal varies by the condition and the kind of variant present. Over time, how the body functions is shaped by many factors, including age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, it can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This is a common reason why the same treatment can work well for one person, seem weaker for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. Understanding this can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ATP5F1A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
ATP5F1A entered genetics through the long scientific effort to understand how cells make energy, especially work on the ATP synthase complex in mitochondria. In recent decades, awareness of this gene’s role has grown as researchers linked older biochemistry findings to specific human genes. The broader ATP synthase story was central to modern bioenergetics, including landmark work in the late 20th century that clarified how this enzyme complex operates. As medical science evolved, so did understanding of this gene, and ATP5F1A was also known for many years by the earlier name ATP5A1. More recent sequencing studies connected variants in the ATP5F1A gene with inherited mitochondrial conditions, bringing the gene from laboratory research into clinical genetics.